antipyrine has been researched along with Cancer of Lung in 14 studies
Antipyrine: An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29)
antipyrine : A pyrazolone derivative that is 1,2-dihydropyrazol-3-one substituted with methyl groups at N-1 and C-5 and with a phenyl group at N-2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "He had been treated for lung cancer by chemotherapy and irradiation 3 years earlier." | 1.40 | [Case of cardiac tamponade during the treatment of acute cerebral infarction]. ( Nagasawa, H; Ono, H; Tanaka, H; Yamakawa, T, 2014) |
| "Pretreatment with edaravone scavenged the SN38-produced reactive oxygen species, and inhibited the SN38-induced activation of NF-kB." | 1.33 | The radical scavenger edaravone enhances the anti-tumor effects of CPT-11 in murine colon cancer by increasing apoptosis via inhibition of NF-kappaB. ( Handa, O; Higashihara, H; Ishikawa, T; Kokura, S; Naito, Y; Nakabe, N; Sakamoto, N; Takagi, T; Yoshida, N; Yoshikawa, T, 2005) |
| "Antipyrine half life was significantly higher in adenocarcinoma in comparison with other types of cancer." | 1.29 | [Antipyrine metabolism in lung cancer patients]. ( Gaździk, W; Radzikowska, E; Rowińska-Zakrzewska, E, 1993) |
| "Antipyrine clearance was measured in 7 patients with bronchogenic carcinoma and in 13 normal subjects and 7 patients with chronic lund disease." | 1.26 | Antipyrine metabolism and bronchogenic carcinoma. ( Ambre, J; Bures, F; Deason, K; Graeff, D; Haupt, D, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (42.86) | 18.7374 |
| 1990's | 5 (35.71) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nagasawa, H | 1 |
| Ono, H | 1 |
| Tanaka, H | 1 |
| Yamakawa, T | 1 |
| Nishio, M | 1 |
| Matsuda, M | 1 |
| Ohyanagi, F | 1 |
| Sato, Y | 1 |
| Okumura, S | 1 |
| Tabata, D | 1 |
| Morikawa, A | 1 |
| Nakagawa, K | 1 |
| Horai, T | 1 |
| Kokura, S | 1 |
| Yoshida, N | 1 |
| Sakamoto, N | 1 |
| Ishikawa, T | 1 |
| Takagi, T | 1 |
| Higashihara, H | 1 |
| Nakabe, N | 1 |
| Handa, O | 1 |
| Naito, Y | 1 |
| Yoshikawa, T | 1 |
| Kellermann, G | 2 |
| Jett, JR | 2 |
| Luyten-Kellermann, M | 2 |
| Moses, HL | 2 |
| Fontana, RS | 2 |
| Radzikowska, E | 3 |
| Gaździk, W | 2 |
| Rowińska-Zakrzewska, E | 2 |
| Oniszh, K | 1 |
| Chojak, E | 1 |
| Ambre, J | 1 |
| Graeff, D | 1 |
| Bures, F | 1 |
| Haupt, D | 1 |
| Deason, K | 1 |
| Tschanz, C | 1 |
| Hignite, CE | 1 |
| Huffman, DH | 1 |
| Azarnoff, DL | 1 |
| Pelkonen, O | 1 |
| Law, MR | 1 |
| Dogra, SC | 1 |
| Khanduja, KL | 1 |
| Sharma, RR | 1 |
| Breslow, DS | 1 |
| Edwards, EI | 1 |
| Newburg, NR | 1 |
2 reviews available for antipyrine and Cancer of Lung
| Article | Year |
|---|---|
Carcinogen metabolism and individual susceptibility.
Topics: Acetylation; Animals; Antipyrine; Aryl Hydrocarbon Hydroxylases; Carcinogens; Debrisoquin; Forecasti | 1992 |
Genetic predisposition to lung cancer.
Topics: Antigens, Neoplasm; Antipyrine; Aryl Hydrocarbon Hydroxylases; Chromosome Aberrations; Chromosome Di | 1990 |
1 trial available for antipyrine and Cancer of Lung
| Article | Year |
|---|---|
[Initial prospective evaluation of cancer incidence in relation to metabolism of antipyrine and family history in patients with lung cancer].
Topics: Adult; Antipyrine; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies | 1996 |
11 other studies available for antipyrine and Cancer of Lung
| Article | Year |
|---|---|
[Case of cardiac tamponade during the treatment of acute cerebral infarction].
Topics: Acute Disease; Adenocarcinoma; Anterior Cerebral Artery; Antipyrine; Aspirin; Cardiac Tamponade; Cer | 2014 |
Antipyrine test predicts pharmacodynamics in docetaxel and cisplatin combination chemotherapy.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Com | 2005 |
The radical scavenger edaravone enhances the anti-tumor effects of CPT-11 in murine colon cancer by increasing apoptosis via inhibition of NF-kappaB.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Anti | 2005 |
Variation of microsomal mixed function oxidase(s) and human lung cancer.
Topics: Aged; Antipyrine; Aryl Hydrocarbon Hydroxylases; Half-Life; Humans; Lung Neoplasms; Male; Metabolic | 1980 |
[Antipyrine metabolism in lung cancer patients].
Topics: Adenocarcinoma; Antipyrine; Female; Half-Life; Humans; Lung Neoplasms; Male; Middle Aged; Reference | 1993 |
Antipyrine metabolism in lung cancer patients and their relatives.
Topics: Adult; Aged; Antipyrine; Aryl Hydrocarbon Hydroxylases; Biotransformation; Disease Susceptibility; E | 1997 |
Antipyrine metabolism and bronchogenic carcinoma.
Topics: Adult; Antipyrine; Carcinoma, Bronchogenic; Humans; Liver; Lung Diseases; Lung Neoplasms; Male; Smok | 1977 |
Aryl hydrocarbon hydroxylase in man and lung cancer.
Topics: Antipyrine; Carcinoma; Genetic Variation; Humans; Hydrocarbons; Lung Neoplasms; Male; Mixed Function | 1978 |
Metabolic disposition of antipyrine in patients with lung cancer.
Topics: Adult; Aged; Antipyrine; Female; Humans; Lung Neoplasms; Male; Metabolic Clearance Rate; Middle Aged | 1977 |
Hepatic drug-metabolizing enzymes in lung tumor-bearing rats.
Topics: Animals; Antipyrine; Benzo(a)pyrene; Cytochrome P-450 Enzyme System; Liver; Lung Neoplasms; Male; Mi | 1985 |
Divinyl ether-maleic anhydride (pyran) copolymer used to demonstrate the effect of molecular weight on biological activity.
Topics: Alanine Transaminase; Aminopyrine; Animals; Antineoplastic Agents; Antipyrine; Carcinoma, Ehrlich Tu | 1973 |